Features | Partner Sites | Information | LinkXpress
Sign In
Bio-Rad Diabetes Division

Industry News

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen. More...
14 Jul 2015

Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens

According to a new market analysis, next generation sequencing may impact the infectious diseases IVD sector by bypassing some of the downside of PCR-based testing, as NGS can provide more flexibility and responsiveness in identification of new pathogenic strains.  More...
07 Jul 2015

Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics

Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.  More...
06 Jul 2015

Cloud-Based Systems Becoming Key Pillar in eHealth Strategy

Cloud-based laboratory information management systems are becoming a key pillar in Europe’s e-Health strategy as data-management solutions for modern testing will generate more demand for these systems.  More...
29 Jun 2015

Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer

New next generation sequencing test panels have been developed to provide more affordable advanced NGS testing that can help doctors choose the most effective cancer treatments based on tumor type and an individual’s genetic profile, an important step towards making personalized medicine broadly accessible. First launch is of a NGS colon cancer test panel.  More...
25 May 2015

New Point of Care Test for Anemia Developed

New diagnostic technology may shift some hemoglobin testing for anemia out of clinical laboratories and into near-patient settings and it may also be possible to use this new diagnostic device for patient self-testing.  More...
20 May 2015

Main Factors Driving Revenue Growth in Clinical Chemistry Identified

According to a report by Kalorama Information, the overall growth in the clinical chemistry market will be modest, driven mainly by new tests and demographic changes, including an aging population and increasing number of people at risk of cardiovascular disease, such as those with hypertension, diabetes mellitus, and abdominal obesity. More...
04 May 2015

LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2015 Globetech Media. All rights reserved.